Oragenics Inc (OGEN) stock
OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.20−0.15 (-42.59%)
Close on Nov 13, 2026Market cap $906.90KP/E –Yield –
Oragenics operating margin
Operating margin is operating income as a percentage of revenue.
Oragenics's operating margin for the twelve months ending Dec 31, 2023 was -55519.9%. For fiscal 2023 it was -55519.9%, against -10964.6% the year before. The highest annual figure on record is -508.6% in fiscal 2011.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -55519.9% | −44555.3 |
| FY2022 | Dec 31, 2022 | -10964.6% | +7165.7 |
| FY2021 | Dec 31, 2021 | -18130.3% | −17511.5 |
| FY2014 | Dec 31, 2014 | -618.8% | +951.6 |
| FY2013 | Dec 31, 2013 | -1570.4% | −636.9 |
| FY2012 | Dec 31, 2012 | -933.5% | −424.9 |
| FY2011 | Dec 31, 2011 | -508.6% | +95.2 |
| FY2010 | Dec 31, 2010 | -603.8% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2023 | Sep 30, 2023 | -28053.1% | −16192.8 |
| Q2 FY2023 | Jun 30, 2023 | -23621.7% | +6943.4 |
| Q1 FY2023 | Mar 31, 2023 | -17063.1% | – |
| Q3 FY2022 | Sep 30, 2022 | -4540.0% | – |
| Q2 FY2022 | Jun 30, 2022 | -11860.3% | – |
| Q1 FY2022 | Mar 31, 2022 | -30565.1% | – |
See a number that looks wrong?